E-LIB Suche - Ergebnisse für: Nikanjam, Mina

1

Reverse repurposing: Potential utility of cancer drugs in n..:

Nikanjam, Mina ; Wells, Kaitlyn ; Kato, Shumei...
Med. , 2024

Link: https://doi.org/10.1016/..

2

Critical insights into the evolving drug‐approval process i..:

Nikanjam, Mina ; Kurzrock, Razelle
Cancer. 130 (2024) 5 - p. 665-667 , 2024

Link: https://doi.org/10.1002/..

3

At the right dose: personalised (N-of-1) dosing for precisi..:

Nikanjam, Mina ; Kato, Shumei ; Sicklick, Jason K..
European Journal of Cancer. 194 (2023) - p. 113359 , 2023

Link: https://doi.org/10.1016/..

4

Combination high-dose interleukin-2 and nivolumab for progr..:

Nikanjam, Mina ; Mullen, Jaren ; Yacoub, Carol.
Journal of Medical Case Reports. 16 (2022) 1 - p. , 2022

Link: https://doi.org/10.1186/..

5

Liquid biopsy: current technology and clinical applications:

Nikanjam, Mina ; Kato, Shumei ; Kurzrock, Razelle
Journal of Hematology & Oncology. 15 (2022) 1 - p. , 2022

Link: https://doi.org/10.1186/..

6

Of Mice, Not Men: When the Bench-to-Bedside Bridge Is Broke:

Nikanjam, Mina ; Kato, Shumei ; Kurzrock, Razelle
Journal of Immunotherapy and Precision Oncology. 5 (2022) 4 - p. 87-89 , 2022

Link: https://doi.org/10.36401..

7

S-warfarin limited sampling strategy with a population phar..:

Tran, Lana ; Nikanjam, Mina ; Capparelli, Edmund V....
European Journal of Clinical Pharmacology. 77 (2021) 9 - p. 1349-1356 , 2021

Link: https://doi.org/10.1007/..

8

Molecular profiling of advanced malignancies guides first-l..:

Sicklick, Jason K. ; Kato, Shumei ; Okamura, Ryosuke...
Genome Medicine. 13 (2021) 1 - p. , 2021

Link: https://doi.org/10.1186/..

9

Expression of TIM3/VISTA checkpoints and the CD68 macrophag..:

Kato, Shumei ; Okamura, Ryosuke ; Kumaki, Yuichi...
OncoImmunology. 9 (2020) 1 - p. , 2020

Link: https://doi.org/10.1080/..

10

Efficacy and safety of anticancer drug combinations: a meta..:

Jardim, Denis L. ; De Melo Gagliato, Débora ; Nikanjam, Mina..
OncoImmunology. 9 (2020) 1 - p. , 2020

Link: https://doi.org/10.1080/..

11

Demographics, Prior Therapies, and Reasons for Cemiplimab T..:

Rabinowits, Guilherme ; Homsi, Jade ; Nikanjam, Mina...
SKIN The Journal of Cutaneous Medicine. 4 (2020) 6 - p. s125 , 2020

Link: https://doi.org/10.25251..

12

Review of precision cancer medicine: Evolution of the treat..:

Tsimberidou, Apostolia M. ; Fountzilas, Elena ; Nikanjam, Mina.
Cancer Treatment Reviews. 86 (2020) - p. 102019 , 2020

Link: https://doi.org/10.1016/..

13

Real-world data from a molecular tumor board demonstrates i..:

Kato, Shumei ; Kim, Ki Hwan ; Lim, Hyo Jeong...
Nature Communications. 11 (2020) 1 - p. , 2020

Link: https://doi.org/10.1038/..

14

Model Informed Development of VRC01 in Newborn Infants Usin..:

Li, Jerry ; Nikanjam, Mina ; Cunningham, Coleen K....
Clinical Pharmacology & Therapeutics. 109 (2020) 1 - p. 184-192 , 2020

Link: https://doi.org/10.1002/..

15

Clinical implications of plasma circulating tumor DNA in gy..:

Charo, Lindsey M. ; Eskander, Ramez N. ; Okamura, Ryosuke...
Molecular Oncology. 15 (2020) 1 - p. 67-79 , 2020

Link: https://doi.org/10.1002/..